Home
SLP
SLP News

Latest Simulations Plus Inc. (SLP) News on November 16, 2025

Wall Street Analysts Believe Simulations Plus (SLP) Could Rally 33.57%: Here's is How to Trade

Zacks

2 days ago

Wall Street Analysts Believe Simulations Plus (SLP) Could Rally 33.57%: Here's is How to Trade

Blink Charging (BLNK) Reports Q3 Loss, Lags Revenue Estimates

Zacks

9 days ago

Blink Charging (BLNK) Reports Q3 Loss, Lags Revenue Estimates

Will Simulations Plus (SLP) Beat Estimates Again in Its Next Earnings Report?

Zacks

13 days ago

Will Simulations Plus (SLP) Beat Estimates Again in Its Next Earnings Report?

Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

Business Wire

25 days ago

Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

Here’s Why Conestoga Capital Advisors Decided to Sell Simulations Plus (SLP)

Insider Monkey

a month ago

Here’s Why Conestoga Capital Advisors Decided to Sell Simulations Plus (SLP)

Argus Research

5 months ago

SLP: Lowering target price to $18.00

Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call

Business Wire

5 months ago

Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call

Simulations Plus price target lowered to $36 from $45 at Craig-Hallum

TipRanks

5 months ago

Simulations Plus price target lowered to $36 from $45 at Craig-Hallum

Simulations Plus (NASDAQ:SLP) Will Be Hoping To Turn Its Returns On Capital Around

Simply Wall St.

5 months ago

Simulations Plus (NASDAQ:SLP) Will Be Hoping To Turn Its Returns On Capital Around

SLP Cuts FY25 Revenue Outlook, Begins Strategic Reorganization

Zacks

5 months ago

SLP Cuts FY25 Revenue Outlook, Begins Strategic Reorganization

Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

Business Wire

5 months ago

Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

MT Newswires

5 months ago

Update: Simulations Plus Cuts Full-Year Revenue Outlook; Shares Down Pre-Bell

Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

Business Wire

5 months ago

Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

Argus Research

5 months ago

SLP: Rating decreased to a HOLD

Simulations Plus Releases ADMET Predictor® 13

Business Wire

5 months ago

Simulations Plus Releases ADMET Predictor® 13

High Growth Tech Stocks in the US to Watch This May 2025

Simply Wall St.

6 months ago

High Growth Tech Stocks in the US to Watch This May 2025

3 Intriguing Stocks Estimated At Up To 42.7% Below Intrinsic Value

Simply Wall St.

6 months ago

3 Intriguing Stocks Estimated At Up To 42.7% Below Intrinsic Value

3 Growth Companies With High Insider Ownership And 161% Earnings Growth

Simply Wall St.

6 months ago

3 Growth Companies With High Insider Ownership And 161% Earnings Growth

SLP Advances Predictive Toxicology With DILIsym 11: Shares to Benefit?

Zacks

6 months ago

SLP Advances Predictive Toxicology With DILIsym 11: Shares to Benefit?

Simulations Plus Releases DILIsym® 11

Business Wire

6 months ago

Simulations Plus Releases DILIsym® 11

Are Simulations Plus, Inc.'s (NASDAQ:SLP) Mixed Financials Driving The Negative Sentiment?

Simply Wall St.

6 months ago

Are Simulations Plus, Inc.'s (NASDAQ:SLP) Mixed Financials Driving The Negative Sentiment?

Argus Research

6 months ago

SLP: Raising target price to $33.00

Argus Research

6 months ago

SLP: Lowering target price to $30.00

2 ‘Strong Buy’ Stocks That Are Crashing the Market in April

TipRanks

7 months ago

2 ‘Strong Buy’ Stocks That Are Crashing the Market in April

Argus Research

7 months ago

SLP: Raising target price to $37.00

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Business Wire

7 months ago

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Argus Research

7 months ago

SLP: Raising target price to $34.00

Argus Research

7 months ago

SLP: What does Argus have to say about SLP?

3 Leading Stocks Estimated To Be Up To 45.9% Below Intrinsic Value

Simply Wall St.

7 months ago

3 Leading Stocks Estimated To Be Up To 45.9% Below Intrinsic Value

Thomson Reuters StreetEvents

7 months ago

Q2 2025 Simulations Plus Inc Earnings Call

Simulations Plus Inc (SLP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com

7 months ago

Simulations Plus Inc (SLP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Simulations Plus (SLP) Tops Q2 Earnings and Revenue Estimates

Zacks

7 months ago

Simulations Plus (SLP) Tops Q2 Earnings and Revenue Estimates

MT Newswires

7 months ago

Simulations Plus Q2 Earnings Lower, Sales Higher; Sets Outlook

Associated Press Finance

7 months ago

Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

Business Wire

7 months ago

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

US High Growth Tech Stocks To Watch In April 2025

Simply Wall St.

7 months ago

US High Growth Tech Stocks To Watch In April 2025

Argus Research

7 months ago

SLP: Lowering target price to $25.00

April 2025's Leading Growth Companies With High Insider Ownership

Simply Wall St.

7 months ago

April 2025's Leading Growth Companies With High Insider Ownership

Argus Research

8 months ago

SLP: Lowering target price to $26.00

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

Business Wire

8 months ago

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

The past three years for Simulations Plus (NASDAQ:SLP) investors has not been profitable

Simply Wall St.

8 months ago

The past three years for Simulations Plus (NASDAQ:SLP) investors has not been profitable

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

Business Wire

8 months ago

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

Argus Research

8 months ago

SLP: Lowering target price to $30.00

Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 30% Below Their Intrinsic Value Estimate

Simply Wall St.

9 months ago

Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 30% Below Their Intrinsic Value Estimate

Argus Research

9 months ago

SLP: Rating increased to a HOLD

Argus Research

9 months ago

SLP: What does Argus have to say about SLP?

US Growth Stocks With Insider Ownership As High As 25%

Simply Wall St.

9 months ago

US Growth Stocks With Insider Ownership As High As 25%

Argus Research

9 months ago

SLP: Raising target price to $28.00

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

Business Wire

9 months ago

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

Is Now The Time To Look At Buying Simulations Plus, Inc. (NASDAQ:SLP)?

Simply Wall St.

9 months ago

Is Now The Time To Look At Buying Simulations Plus, Inc. (NASDAQ:SLP)?

Argus Research

10 months ago

SLP: Rating decreased to a SELL

MT Newswires

10 months ago

Simulations Plus Partners With Enabling Technologies Consortium to Advance GastroPlus Platform

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

Business Wire

10 months ago

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

Argus Research

10 months ago

SLP: Raising target price to $33.00

There May Be Reason For Hope In Simulations Plus' (NASDAQ:SLP) Disappointing Earnings

Simply Wall St.

10 months ago

There May Be Reason For Hope In Simulations Plus' (NASDAQ:SLP) Disappointing Earnings

Argus Research

10 months ago

SLP: Rating increased to a HOLD

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.

10 months ago

Exploring High Growth Tech Stocks in the US Market

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

Business Wire

10 months ago

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

US Growth Companies With High Insider Ownership In January 2025

Simply Wall St.

10 months ago

US Growth Companies With High Insider Ownership In January 2025

Simulations Plus First Quarter 2025 Earnings: EPS Misses Expectations

Simply Wall St.

10 months ago

Simulations Plus First Quarter 2025 Earnings: EPS Misses Expectations

Thomson Reuters StreetEvents

10 months ago

Q1 2025 Simulations Plus Inc Earnings Call

MT Newswires

10 months ago

KeyBanc Lowers Price Target on Simulations Plus to $35 From $40, Keeps Overweight Rating

Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

GuruFocus.com

10 months ago

Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

Simulations Plus (SLP) Lags Q1 Earnings Estimates

Zacks

10 months ago

Simulations Plus (SLP) Lags Q1 Earnings Estimates

MT Newswires

10 months ago

Simulations Plus Fiscal Q1 Adjusted EPS Down, Revenue Up; Guidance Unchanged -- Shares Drop After Hours

Associated Press Finance

10 months ago

Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

Business Wire

10 months ago

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

3 Software Stocks to Keep an Eye on Amid Industry Headwinds

Zacks

10 months ago

3 Software Stocks to Keep an Eye on Amid Industry Headwinds

Simulations Plus (SLP) Fell due to Concerns Over the Funding Environment

Insider Monkey

10 months ago

Simulations Plus (SLP) Fell due to Concerns Over the Funding Environment

Simulations Plus (NASDAQ:SLP) Will Be Hoping To Turn Its Returns On Capital Around

Simply Wall St.

10 months ago

Simulations Plus (NASDAQ:SLP) Will Be Hoping To Turn Its Returns On Capital Around

Argus Research

a year ago

SLP: Lowering target price to $23.00

Argus Research

a year ago

SLP: Lowering target price to $24.00

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

Business Wire

a year ago

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

US Growth Stocks With High Insider Ownership For December 2024

Simply Wall St.

a year ago

US Growth Stocks With High Insider Ownership For December 2024

Argus Research

a year ago

SLP: What does Argus have to say about SLP?

Simulations Plus, Inc.'s (NASDAQ:SLP) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Simply Wall St.

a year ago

Simulations Plus, Inc.'s (NASDAQ:SLP) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Argus Research

a year ago

SLP: What does Argus have to say about SLP?

Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know

Zacks

a year ago

Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know

Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?

Zacks

a year ago

Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?

Simulations Plus to Participate in the BTIG Digital Health Forum

Business Wire

a year ago

Simulations Plus to Participate in the BTIG Digital Health Forum

US Growth Stocks With High Insider Ownership Seeing Up To 115% Earnings Growth

Simply Wall St.

a year ago

US Growth Stocks With High Insider Ownership Seeing Up To 115% Earnings Growth

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

Business Wire

a year ago

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

Argus Research

a year ago

SLP: Raising target price to $26.00

Salesforce.com (CRM) Moves 6.1% Higher: Will This Strength Last?

Zacks

a year ago

Salesforce.com (CRM) Moves 6.1% Higher: Will This Strength Last?

How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%

Zacks

a year ago

How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%

We Think Simulations Plus' (NASDAQ:SLP) Solid Earnings Are Understated

Simply Wall St.

a year ago

We Think Simulations Plus' (NASDAQ:SLP) Solid Earnings Are Understated

Simulations Plus to Participate in the Stephens Annual Investment Conference

Business Wire

a year ago

Simulations Plus to Participate in the Stephens Annual Investment Conference

Argus Research

a year ago

SLP: Lowering target price to $23.00

Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Thomson Reuters StreetEvents

a year ago

Q4 2024 Simulations Plus Inc Earnings Call

Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth

Zacks

a year ago

Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth

High Growth Tech Stocks to Watch in October 2024

Simply Wall St.

a year ago

High Growth Tech Stocks to Watch in October 2024

Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ...

GuruFocus.com

a year ago

Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ...

Simulations Plus (SLP) Surpasses Q4 Earnings Estimates

Zacks

a year ago

Simulations Plus (SLP) Surpasses Q4 Earnings Estimates

Associated Press Finance

a year ago

Simulations Plus: Fiscal Q4 Earnings Snapshot

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

Business Wire

a year ago

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

Simulations Plus (SLP) Fell Due to EBITDA Below Expectations

Insider Monkey

a year ago

Simulations Plus (SLP) Fell Due to EBITDA Below Expectations

3 US Growth Companies With Up To 36% Insider Ownership

Simply Wall St.

a year ago

3 US Growth Companies With Up To 36% Insider Ownership

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

Business Wire

a year ago

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

Argus Research

a year ago

SLP: Rating decreased to a SELL

Share on Social Networks: